719 related articles for article (PubMed ID: 32590944)
1. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
[TBL] [Abstract][Full Text] [Related]
2. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Geng W; Zhang Q; Liu J; Tian X; Zhen L; Song D; Yang Y; Meng H; Wang Y; Chen J
J Interv Cardiol; 2018 Apr; 31(2):136-143. PubMed ID: 29171086
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy study of prourokinase injection during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
Jiang W; Xiong X; Du X; Ma H; Li W; Cheng F
Coron Artery Dis; 2021 Jan; 32(1):25-30. PubMed ID: 32310850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
Fu Y; Gu XS; Hao GZ; Jiang YF; Fan WZ; Fan YM; Wei QM; Fu XH; Li YJ
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):839-845. PubMed ID: 30773796
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden.
Wang X; Liu H; Wu H; Xiao Y; Bai S; Li X; Li X; Zhang L; Chen T; Li H; Liu J; Du R
Coron Artery Dis; 2020 Sep; 31(6):493-499. PubMed ID: 32073417
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute ST-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay.
Han YL; Liu JN; Jing QM; Ma YY; Jiang TM; Pu K; Zhao RP; Zhao X; Liu HW; Xu K; Wang G; Wang B; Sun RH; Wang J
Cardiovasc Ther; 2013 Oct; 31(5):285-90. PubMed ID: 23634911
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
Yin XS; Huang YW; Li ZP; Dong JL; Zou JM; Tian L; Yang J
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5802-5813. PubMed ID: 36066155
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
Zhao L; Zhao Z; Chen X; Li J; Liu J; Li G;
Heart Vessels; 2018 May; 33(5):507-512. PubMed ID: 29209778
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.
Pelliccia F; Greco C; Tanzilli G; Viceconte N; Schiariti M; Gaudio C
J Thromb Thrombolysis; 2021 Jan; 51(1):212-216. PubMed ID: 32472307
[TBL] [Abstract][Full Text] [Related]
12. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.
Chen GX; Wang HN; Zou JL; Yuan XX
World J Emerg Med; 2020; 11(3):157-163. PubMed ID: 32351648
[TBL] [Abstract][Full Text] [Related]
13. Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial Infarction.
Maznyczka AM; McCartney PJ; Oldroyd KG; Lindsay M; McEntegart M; Eteiba H; Rocchiccioli P; Good R; Shaukat A; Robertson K; Kodoth V; Greenwood JP; Cotton JM; Hood S; Watkins S; Macfarlane PW; Kennedy J; Tait RC; Welsh P; Sattar N; Collison D; Gillespie L; McConnachie A; Berry C
J Am Heart Assoc; 2020 Feb; 9(3):e014066. PubMed ID: 31986989
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.
Yu S; Jia H; Ding S; Zhang M; Li F; Xu P; Tian Y; Ma L; Gong L; Feng J; Sun Z; Qian F; Li H
J Cardiothorac Surg; 2024 Apr; 19(1):180. PubMed ID: 38580976
[TBL] [Abstract][Full Text] [Related]
15. Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization.
Xiao Y; Fu X; Wang Y; Fan Y; Wu Y; Wang W; Zhang Q
Coron Artery Dis; 2019 Dec; 30(8):555-563. PubMed ID: 30998610
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
[TBL] [Abstract][Full Text] [Related]
17. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.
Ghonim AA; Mostafa A; Emara A; Algazzar AS; Qutub MA
Cardiovasc J Afr; 2019 Sep/Oct 23; 30(5):285-289. PubMed ID: 31194213
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
[TBL] [Abstract][Full Text] [Related]
20. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
